SI
NVCR icon

Scout Investments’s NovoCure NVCR Stock Holding History

Scout Investments’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-28,890
Closed -$3.36M – 318
2021
Q3 		$3.36M Sell
28,890
-23,748
-45% -$3.59M 0.05% 281
2021
Q2 		$11.7M Sell
52,638
-24,588
-32% -$4.78M 0.17% 175
2021
Q1 		$10.2M Sell
77,226
-24,636
-24% -$3.9M 0.15% 209
2020
Q4 		$17.6M Sell
101,862
-1,017
-1% -$139K 0.32% 123
2020
Q3 		$11.5M Buy
+102,879
New +$8.23M 0.25% 149

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Scout Investments's NVCR Position: Q4 2021 in Review

Scout Investments sold out of NovoCure (NVCR) in Q4 2021, closing a stake of 28,890 shares — an estimated $3.36M sold.

Scout Investments first reported a position in NVCR in Q3 2020 and held it in 5 quarters. The position peaked at $17.6M in Q4 2020. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • Scout Investments reported no remaining NovoCure position as of Q4 2021 after selling out during the quarter.
  • Scout Investments sold 28,890 NovoCure shares in Q4 2021, an estimated $3.36M.
  • Scout Investments first reported a position in NovoCure in Q3 2020 and held it in 5 quarters.
  • Scout Investments's NovoCure position peaked at $17.6M in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on Scout Investments's 13F filing for Q4 2021, filed 14 Jan 2022.